Sunday, March 7, 2021
Woman dies after vaccination
Vienna withdraws AstraZeneca fee
In Austria, complications occurred in two women after vaccination with the Astrazenka vaccine. One dies Although no connection can be identified, vaccination appointments have been canceled. The Federal Office for Safety in Health Care is withdrawing the batch.
After one death and one illness, Austria stopped vaccinating with a batch of AstraZeneca vaccine as a precaution. The Federal Office for Health Safety (BASG) announced that there were two reports of a temporary relationship with vaccination from the same batch of vaccine at Zwettel State Hospital in Lower Austria. “There is currently no evidence of a causal relationship with vaccination,” the authority said. Nevertheless, vaccination appointments were canceled. Austrian media cite BASG, saying, “At the moment, all necessary investigations are going at full speed with the involvement of the experts concerned to be able to deal with the most completely possible connections.”
Stopping vaccination with batches is a precautionary measure. A 49-year-old woman died as a result of severe coagulation disorders, ten days before she received her first dose of the AstraZeneca vaccine. With coagulation disorders, he was admitted to the intensive care unit of Vienna General Hospital last weekend, where he then died.
The office said that a 35-year-old woman suffered from pulmonary embolism. “Based on known clinical data, a causal relationship cannot be established, as thrombotic events in particular are not among the known or specific side effects of the vaccine under consideration.”
quick check
According to media reports, both women are nurses of Zwettl Clinic. Both were vaccinated from the same batch of the AstraZeneca vaccine. AstraZeneca said in an introductory statement: “In the interests of all those who have been awaiting vaccination for a long time, we would like to investigate as quickly as possible how this unfortunate incident happened.”
The company is in close contact with the Health and Food Safety Agency (AGES) and “fully” supports their investigation. The vaccine was approved by the European Medical Agency (EMA) and the World Health Organization (WHO) based on a global clinical program with 23,000 participants. “All these reviews have shown that the Kovid-19 vaccine AstraZeneca is safe and effective,” the company said.
